11/11/2024

Ondansetron Hydrochloride Injection

Products Affected - Description

- Ondansetron injection, Hikma, 2 mg/mL, 20 mL vial, 1 count, NDC 00641-6079-01

Reason for the Shortage

- Apotex has ondansetron injection available.
- Avet has ondansetron injection available.
- AuroMedics is no longer marketing ondansetron injection.
- Fosun has ondansetron injection available.
- Fresenius Kabi has ondansetron injection available.
- Hikma did not provide a reason for the shortage.
- Viatris discontinued ondansetron 2 mL vials in December 2021 and the 20 mL vials were discontinued in June 2022.
- Pfizer has ondansetron injection available.
- Sagent has ondansetron injection available. The 20 mL vials were discontinued in 2021.
- Novartis discontinued Zofran 20 mL vials in May 2018.

Available Products

- Ondansetron injection, Apotex, 2 mg/mL, 2 mL vial, 25 count, NDC 60505-6130-05
- Ondansetron injection, Avet Pharmaceuticals, 2 mg/mL, 2 mL vial, 25 count, NDC 23155-0547-42
- Ondansetron injection, Avet Pharmaceuticals, 2 mg/mL, 20 mL vial, 1 count, NDC 23155-0549-31
- Ondansetron injection, Fosun Pharma, 2 mg/mL, 2 mL vial, 25 count, NDC 72266-0123-01
- Ondansetron injection, Fosun Pharma, 2 mg/mL, 20 mL vial, 1 count, NDC 72266-0124-01
- Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL RFID prefilled syringe, 24 count, NDC 76045-0216-20
- Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL vial, 25 count, NDC 63323-0373-02
- Ondansetron injection, Fresenius Kabi, 2 mg/mL, 20 mL vial, 1 count, NDC 63323-0374-20
- Ondansetron injection, Hikma, 2 mg/mL, 2 mL vial, 25 count, NDC 00641-6078-25
- Ondansetron injection, Pfizer, 2 mg/mL, 2 mL vial, 25 count, NDC 00409-4755-03
- Ondansetron injection, Pfizer, 2 mg/mL, 20 mL vial, 1 count, NDC 00409-4759-01
- Ondansetron injection, Sagent, 2 mg/mL, 2 mL vial, 25 count, NDC 25021-0777-02

Estimated Resupply Dates

- Hikma has ondansetron 2 mg/mL 20 mL vials on back order and the company estimates a release date of late-November 2024.

Updated

Updated November 11, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 8, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.